The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis-Reference-Cited by-同舟云学术

The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis

Published:2018-04-14 Issue:6 Volume:5 Page:710-716
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Cortés-Vicente Elena¹²,Rojas-Garcia Ricard¹²,Díaz-Manera Jordi¹²,Querol Luis¹²,Casasnovas Carlos³,Guerrero-Sola Antonio⁴,Muñoz-Blanco José Luis⁵,Bárcena-Llona José Eulalio⁶,Márquez-Infante Celedonio⁷,Pardo Julio⁸,Martínez-Fernández Eva María⁹,Usón Mercedes¹⁰,Oliva-Nacarino Pedro¹¹,Sevilla Teresa²¹²¹³,Illa Isabel¹²

Affiliation:

1. Neuromuscular Diseases Unit; Department of Neurology; Hospital de la Santa Creu i Sant Pau; Universitat Autònoma de Barcelona; Barcelona Spain

2. Centre for Biomedical Network Research on Rare Diseases (CIBERER); Madrid Spain

3. Neuromuscular Diseases Unit; Department of Neurology; Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat; Barcelona Spain

4. Neuromuscular Diseases Unit; Departament of Neurology; Hospital Universitario Clínico San Carlos; Madrid Spain

5. ALS-Neuromuscular Unit; Department of Neurology; Hospital General Universitario Gregorio Marañón; IISGM; Madrid Spain

6. Department of Neurology; Hospital Universitario Cruces; Baracaldo Spain

7. Neuromuscular Diseases Unit; Departament of Neurology and Neurophysiology; Hospital Universitario Virgen del Rocío; Sevilla Spain

8. Department of Neurology; Hospital Clínico; Santiago de Compostela Spain

9. Department of Neurology; Hospital Juan Ramón Jiménez; Huelva Spain

10. Department of Neurology; Hospital Son Llàtzer; Palma de Mallorca Spain

11. Department of Neurology; Hospital Universitario Central de Asturias; Oviedo Spain

12. Neuromuscular Unit; Department of Neurology; Hospital Universitari i Politècnic La Fe; Valencia Spain

13. Department of Medicine; University of Valencia; Valencia Spain

Funder

Fondo de Investigación en Salud, Instituto de Salud Carlos III, Ministry of Health (Spain)

European Social Fund

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Reference37 articles.

1. Myasthenia gravis: subgroup classification and therapeutic strategies;Gilhus;Lancet Neurol,2015

2. Cutting edge in myasthenia gravis;Berrih-Aknin;Autoimmun Rev,2013

3. Humoral pathogenesis of myasthenia gravis;Drachman;Ann N Y Acad Sci,1987

4. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model;Engel;Neurology,1977

5. Myasthenia gravis and the neuromuscular junction;Querol;Curr Opin Neurol,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab as a sole steroid-sparing agent in generalized myasthenia gravis: Long-term outcomes;Neurological Sciences;2023-10-13

2. Rituximab treatment in myasthenia gravis;Frontiers in Neurology;2023-10-02

3. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26

4. On the path to evidence-based therapy in neuromuscular disorders;Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders;2023

5. New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies;Journal of Clinical Medicine;2022-10-28